Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone

Journal of Psychopharmacology

Volumn 24, Issue 4, 2010, Pages 627-628

  Kuloglu, M ^a   Ekinci, O ^a   Caykoylu, A ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CLONAZEPAM; ESCITALOPRAM; FLUOXETINE; VENLAFAXINE;

ADULT; BRUXISM; CASE REPORT; CIGARETTE SMOKING; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; LETTER; MAJOR DEPRESSION; MASSETER MUSCLE; MUSCLE TIGHTNESS; PRIORITY JOURNAL; TOOTH PAIN; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUSPIRONE; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SLEEP BRUXISM; TREATMENT OUTCOME;

EID: 77950417496     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109102612     Document Type: Letter

References (15)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, fourth ed, text revision. Washington, DC: American Psychiatric Association.
2. Bostwick, JM, Jaffee, MS (1999) Buspirone as an antidote to SSRIinduced bruxism in 4 cases. J Clin Psychiatry 60: 857-860.
3. Brown, ES, Hong, SC (1999) Antidepressant-induced bruxism successfully treated with gabapentin. J Am Dent Assoc 130: 1467-1469.
4. Ellison, JA, Stanziani, P. (1993) SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry 54: 432-434. (Pubitemid 24020598)
5. Fitzgerald, K., Healy, D. (1995) Dystonias and dyskinesias of the jaw associated with the use of SSRIs. Hum Psychopharmacol 10: 215-219.
6. Gerber, PE, Lynd, LD (1998) Selective serotonin-reuptake inhibitor induced movement disorders. Ann Pharmacother 32: 692-698.
7. Hamilton, M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
8. Jaffee, MS, Bostwick, JM (2000) Buspirone as an antidote to venlafaxine-induced bruxism. Psychosomatics 41: 535-536.
9. Lavigne, GJ, Kato, T., Kotla, A., Sesle, BJ (2003) Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med 14: 30-46.
10. Lavigne, GJ, Lobbezoo, F., Rompre, PH, Nielsen, TA, Montplaisir, J. (1997) Cigarette smoking as a risk or an exacerbating factor for restless leg syndrome and sleep bruxism. Sleep 20: 290-293. (Pubitemid 27276644)
11. Mahmood, I., Sahajwalla, C. (1999) Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 36: 277-287. (Pubitemid 29201736)
12. Moss, LE, Neppe, VM, Drevets, WC (1993) Buspirone in the treatment of tardive dyskinesia. J Clin Psychopharmacol 13: 204-209.
13. Stahl, SM, Grady, MM, Moret, C., Briley, M. (2005) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10: 732-747. (Pubitemid 41443048)
14. Tanda, G., Carboni, E., Frau, R., Di Chiara, G. (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) 115: 285-288. (Pubitemid 24207795)
15. Winocur, E., Gavish, A., Voikovitch, M., Emodi-Perlman, A., Eli, I. (2003) Drugs and bruxism: a critical review. J Orofac Pain 17: 99-111. (Pubitemid 37141299)